Sector

Healthcare Insider Trading Activity

Every SEC Form 4 insider transaction reported by Healthcare companies — biotech, pharmaceuticals, medical devices, and providers — sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Are Healthcare insiders buying or selling?

Healthcare insiders reported 18,210 open-market buys ($40.2B) and 61,326 sells ($210.0B) across 79,536 Form 4 filings from 1,208 companies — a net selling position of $169.7B.

Source: SEC EDGAR Form 4

Key Statistics (as of Sep 4, 2026)

Total Form 4 filings
79,536
SEC EDGAR
Companies
1,208
Insider buys (18,210)
$40.2B
Insider sells (61,326)
$210.0B

Sector sentiment

Net selling

Net insider flow of $169.7B in net selling across 10,598 insider filers.

Most active Healthcare companies

#CompanyForm 4 filings
1MRNAModerna, Inc.822
2NTRANatera, Inc.722
3BLFSBIOLIFE SOLUTIONS INC685
4UTHRUNITED THERAPEUTICS Corp664
5VRTXVERTEX PHARMACEUTICALS INC / MA575
6EWEdwards Lifesciences Corp524
7DXCMDEXCOM INC501
8TWSTTwist Bioscience Corp501
9TDOCTeladoc Health, Inc.473
10CORAMERISOURCEBERGEN CORP448

Recent Healthcare insider transactions

DateTickerInsiderTypeValue
Sep 4, 2026TAKAndrew Stewart PlumpPresident, R&DSale$2.1M
Sep 4, 2026NTRASolomon MoshkevichPRESIDENT, CLINICALDIAGNOSTICSSale$5.9M
Sep 4, 2026SYREHeidy King-JonesOfficerSale$2.5M
Sep 4, 2026SYREScott L BurrowsChief Financial OfficerSale$2.3M
Sep 4, 2026SYRECameron TurtleChief Executive OfficerSale$1.3M
Sep 4, 2026CORTSean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file wSale$2.9M
Sep 4, 2026NTRASteven Leonard ChapmanCEO AND PRESIDENTSale$545.0K
Sep 4, 2026CORTRoberto Wandenkolk VieiraPresident, OncologySale$6.5M
Sep 4, 2026PACSJason Hulse MurrayCo-Founder, CEO & ChairmanSale$2.9M
Sep 4, 2026THCNadja WestDirectorSale$298.1K
Sep 3, 2026FLGTHanlin GaoChief Scientific OfficerSale$32.9K
Sep 3, 2026FLGTJian XiePresident and COOSale$41.8K
Sep 3, 2026AMPHRong ZhouSENIOR EVP, PRODUCTION CENTERSale$75.3K
Sep 3, 2026SIBNJeffrey W DunnDirectorSale$378.2K
Sep 3, 2026TRDAMPM BIOVENTURES 2018, L.P.10% OwnerSale$617.4K
Sep 3, 2026TRDAMPM BioVentures 2014, L.P.10% OwnerSale$617.4K
Sep 3, 2026AXSMMark L. JacobsonChief Operating OfficerSale$2.1M
Sep 3, 2026SEPNDaniel D. LongSVP, Drug DiscoverySale$126.1K
Sep 3, 2026FDMTScott BizilyChief Legal OfficerSale$8.2K
Sep 3, 2026MIRMJolanda HoweSVP, GLOBAL CONTROLLERSale$65.8K

Showing the 20 most recent filings. Screen every Healthcare filing.

Healthcare insider trading FAQ

Are Healthcare insiders buying or selling?

Across 79,536 SEC Form 4 filings in the Healthcare sector, insiders reported 18,210 open-market purchases totaling $40.2B and 61,326 sales totaling $210.0B. That is a net selling position of $169.7B.

Which Healthcare companies have the most insider activity?

Moderna, Inc. (MRNA), Natera, Inc. (NTRA), BIOLIFE SOLUTIONS INC (BLFS), UNITED THERAPEUTICS Corp (UTHR), VERTEX PHARMACEUTICALS INC / MA (VRTX) lead the Healthcare sector by Form 4 filing count.

How many companies file Form 4s in the Healthcare sector?

1,208 Healthcare companies have reported SEC Form 4 insider transactions on Trabud, from 10,598 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly.

Where does Trabud get Healthcare insider trading data?

Directly from SEC EDGAR Form 4 filings. Every transaction on this page is a real filing accepted by the SEC, updated as new filings arrive.

Related Content

Screen every Healthcare insider filing

Filter all 79,536 Healthcare Form 4 filings by transaction value, insider role, market cap, and date — or ask Trabud's AI agent in plain English.

Open the Healthcare screener